Health insurance to cover Nexavar in liver patients

Published: 2010-10-22 06:58:00

Updated: 2010-10-22 06:58:00

The national health insurance is expected to cover Bayer’s Nexavar (sorafenib) tablets in patients with last-stage liver cancer, according to the government.

In a parliamentary inspection on October 19, the Health Insurance Review and Assessment Service said that the government is considering ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK